Comparing Joint (NASDAQ:JYNT) and Eurofins Scient (OTCMKTS:ERFSF)

Eurofins Scient (OTCMKTS:ERFSF) and Joint (NASDAQ:JYNT) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Volatility and Risk

Eurofins Scient has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, Joint has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

Profitability

This table compares Eurofins Scient and Joint’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eurofins Scient	N/A	N/A	N/A
Joint	6.49%	12.02%	3.47%

Insider and Institutional Ownership

76.9% of Joint shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Eurofins Scient and Joint”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eurofins Scient	$8.25 billion	1.89	$537.29 million	N/A	N/A
Joint	$54.90 million	2.17	$2.91 million	$0.27	31.22

Eurofins Scient has higher revenue and earnings than Joint.

Analyst Recommendations

This is a summary of current ratings and price targets for Eurofins Scient and Joint, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eurofins Scient	0	2	1	0	2.33
Joint	1	2	0	0	1.67

Summary

Joint beats Eurofins Scient on 7 of the 11 factors compared between the two stocks.

About Eurofins Scient

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.